Changes in Digestive Health, Satiety and Overall Well-Being after 14 Days of a Multi-Functional GI Primer Supplement.

dietary fiber digestive enzymes digestive health fermented foods functional food gut homeostasis gut microbiota gut motility postbiotics prebiotics supplements well-being

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 09 08 2024
revised: 04 09 2024
accepted: 11 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

A recent review proposed a role for multi-functional food or supplement products in priming the gut to support both digestive and systemic health. Accordingly, we designed and eva-luated the effect of a multi-functional gastrointestinal (GI) primer supplement on participant-reported measures for digestive health, quality-of-life (e.g., energy/vitality and general health), and reasons for satiation (e.g., attitudes towards food and eating). In this single-arm clinical trial, 68 participants with mild digestive symptoms consumed the GI primer supplement daily for 14 days. Digestive symptoms were evaluated daily from baseline (Day 0) through Day 14. At baseline and Day 14, participants reported their stool consistency, reasons for satiation, and quality-of-life measures using validated questionnaires. At Day 14, participants reported significant improvements in all (13/13) digestive symptom parameters (

Identifiants

pubmed: 39339773
pii: nu16183173
doi: 10.3390/nu16183173
pii:
doi:

Types de publication

Journal Article Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Elena Nekrasov (E)

Amway Innovation and Science, Ada, MI 49355, USA.

Alexandra Adorno Vita (AA)

Helfgott Research Institute, National University of Natural Medicine, Portland, OR 97201, USA.

Ryan Bradley (R)

Amway Innovation and Science, Buena Park, CA 90621, USA.
Herbert Wertheim School of Public Health and Human Longevity Science, University of California, La Jolla, CA 92093, USA.

Nikhat Contractor (N)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Nadeesha M Gunaratne (NM)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Marissa Kuehn (M)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Rick Kitisin (R)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Deval Patel (D)

Amway Innovation and Science, Ada, MI 49355, USA.

Erin Woods (E)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Bo Zhou (B)

Amway Innovation and Science, Buena Park, CA 90621, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH